Fluocinolone Acetonide Oil (RLD Derma-Smoothe/FS®) had estimated annual sales of USD 10 million in the U.S. (IQVIA MAT June 2023)
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
Mindset disagrees with and denies the allegations set forth from Reunion.
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
The ninth acquisition since 2018
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
Subscribe To Our Newsletter & Stay Updated
